一个现实世界的药监测研究FDA不良事件报告系统事件对daratumumab
Xiaolin Yun1, Yingying Zhou2, Danna Wu1
1Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Expert opinion on drug safety
|April 11, 2024
概括
这项研究分析了美国食品和药物管理局的数据,以确定与多发性骨髓瘤治疗的达拉图穆马布相关的不良事件 (AE). 检测到意想不到的副作用,需要进一步的临床调查.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 针对CD38的单克隆抗体Daratumumab已被批准用于治疗多发性骨髓瘤.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库被用于安全监测.
- 了解与daratumumab相关的不良事件 (AEs) 对患者安全至关重要.
研究的目的:
- 评估与达拉图穆马布治疗相关的潜在不良事件.
- 通过数据挖掘识别新的或意想不到的安全信号.
- 量化与daratumumab相关的特定不良事件的风险.
主要方法:
- 应用了不成比例分析,包括ROR,PRR,BCPNN和MGPS算法.
- 在FAERS数据库中查询了有关达拉图穆马布相关副作用的报告.
- 使用统计方法检测显著不良事件信号.
主要成果:
- 在超过1000万份报告中,发现了8727个与达拉图穆马布相关的副作用.
- 发现了183个显著不成比例的首选术语 (PT).
- 意想不到的不良事件包括无菌性脑膜炎,白脑病变和瘤溶解综合征;中位数发病时间为11天.
结论:
- 该研究确定了达拉图姆巴的潜在新和意想不到的不良事件信号.
- 建议进行进一步的前性临床研究来证实这些发现.
- 确认这些安全信号将有助于更好地了解达拉图穆马布的风险概况.
更多相关视频
00:05A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
16.3K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
